Source: Annual Congress 2005 - Mechanisms of inflammatory reactions in asthma, COPD and models of allergic airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Førli, O. J. Mellbye, E. Haug, O. Bjørtuft, M. Vatn, J. Kofstad, J. Boe (Oslo, Norway). Cytokines, bone markers and weight in patients with advanced pulmonary disease. Eur Respir J 2005; 26: Suppl. 49, 3749

Member's Comments

No comment yet.

Related content which might interest you: Cytokines and weight gain in underweight patients with advanced pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Immunoglobulins and weight in patients with advanced pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 263s Year: 2002 Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Predictor markers of early pulmonary hypertension in patients with collagen diseases Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Cytokines status, endothelial function in patients with pulmonary diseases Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Associations between variations of adipokines, cytokines and body composition in patients with chronic obstructive pulmonary disease in one year Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Biochemical markers of bone remodeling in children with chronic lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006 Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 688s Year: 2007 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Inflammatory markers in skeletal muscle of low and normal weight COPD patients Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 Inflammatory cytokines of patients with peripheral arterial disease and COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Inflammatory markers in COPD patients with and without cachexia Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis Source: Eur Respir J 2011; 38: 1355-1360 Year: 2011 Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA) Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015